MA26976A1 - Derives du tetrahydropyridine, leur preparation et leur utilisation comme inhibiteur de proliferation de cellules - Google Patents

Derives du tetrahydropyridine, leur preparation et leur utilisation comme inhibiteur de proliferation de cellules

Info

Publication number
MA26976A1
MA26976A1 MA27207A MA27207A MA26976A1 MA 26976 A1 MA26976 A1 MA 26976A1 MA 27207 A MA27207 A MA 27207A MA 27207 A MA27207 A MA 27207A MA 26976 A1 MA26976 A1 MA 26976A1
Authority
MA
Morocco
Prior art keywords
preparation
cell proliferation
proliferation inhibitors
tetrahydropyridine derivatives
tetrahydropyridine
Prior art date
Application number
MA27207A
Other languages
English (en)
Inventor
Guy Georges
Adelbert Grossmann
Olaf Mundigl
Der Saal Wolfgang Von
Tim Sattelkau
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA26976A1 publication Critical patent/MA26976A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
MA27207A 2000-12-23 2003-06-20 Derives du tetrahydropyridine, leur preparation et leur utilisation comme inhibiteur de proliferation de cellules MA26976A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00128487 2000-12-23

Publications (1)

Publication Number Publication Date
MA26976A1 true MA26976A1 (fr) 2004-12-20

Family

ID=8170814

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27207A MA26976A1 (fr) 2000-12-23 2003-06-20 Derives du tetrahydropyridine, leur preparation et leur utilisation comme inhibiteur de proliferation de cellules

Country Status (27)

Country Link
US (1) US6800638B2 (fr)
EP (1) EP1353921B1 (fr)
JP (1) JP2004516325A (fr)
KR (1) KR100836545B1 (fr)
CN (1) CN1213046C (fr)
AR (1) AR035513A1 (fr)
AT (1) ATE323700T1 (fr)
AU (1) AU2002226397B2 (fr)
BG (1) BG107935A (fr)
BR (1) BR0116402A (fr)
CA (1) CA2431471A1 (fr)
CZ (1) CZ20031940A3 (fr)
DE (1) DE60118975T2 (fr)
EC (1) ECSP034664A (fr)
ES (1) ES2261519T3 (fr)
HU (1) HUP0400554A2 (fr)
IL (1) IL156131A0 (fr)
MA (1) MA26976A1 (fr)
MX (1) MXPA03005713A (fr)
NO (1) NO20032830L (fr)
NZ (1) NZ526189A (fr)
PL (1) PL365531A1 (fr)
RU (1) RU2276140C2 (fr)
SK (1) SK9122003A3 (fr)
WO (1) WO2002051842A1 (fr)
YU (1) YU48803A (fr)
ZA (1) ZA200304264B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6706686B2 (en) 2001-09-27 2004-03-16 The Regents Of The University Of Colorado Inhibition of histone deacetylase as a treatment for cardiac hypertrophy
EP1443928B1 (fr) 2001-10-16 2011-07-27 Sloan-Kettering Institute For Cancer Research Traitement des maladies neurodegeneratives et du cancer du cerveau
WO2003083323A1 (fr) 2002-04-01 2003-10-09 Ranko Rakanovic Élément élastique en caoutchouc
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
AU2003900608A0 (en) * 2003-02-11 2003-02-27 Fujisawa Pharmaceutical Co., Ltd. Hdac inhibitor
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1633751A1 (fr) * 2003-06-16 2006-03-15 Chroma Therapeutics Limited Derives de carboline et de betacarboline inhibiteurs de l'enzyme hdac
CN1905881A (zh) * 2003-11-26 2007-01-31 阿托恩药品公司 二胺和亚氨二醋酸异羟肟酸衍生物
US20050137234A1 (en) * 2003-12-19 2005-06-23 Syrrx, Inc. Histone deacetylase inhibitors
WO2005065681A1 (fr) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. Derives de n-hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide et composes associes en tant qu'inhibiteurs d'histone deacetylase pour le traitement du cancer
US7642275B2 (en) 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008530136A (ja) 2005-02-14 2008-08-07 ミイカナ セラピューティクス インコーポレイテッド ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
GB0509223D0 (en) * 2005-05-05 2005-06-15 Chroma Therapeutics Ltd Enzyme inhibitors
JP2008540574A (ja) * 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2615105A1 (fr) * 2005-07-14 2007-01-25 Takeda San Diego, Inc. Inhibiteurs de l'histone deacetylase
EP2275096A3 (fr) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP2258357A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse avec inhibiteur de l'acetylcholinestérase
WO2007047978A2 (fr) 2005-10-21 2007-04-26 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
EP2314289A1 (fr) 2005-10-31 2011-04-27 Braincells, Inc. Modulation de la neurogenese dont la médiation est assurée par récepteur gaba
EP1976835A2 (fr) * 2006-01-13 2008-10-08 Takeda San Diego, Inc. Inhibiteurs des histone desacetylases
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (fr) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenèse par modulation de l'angiotensine
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
WO2008030651A1 (fr) 2006-09-08 2008-03-13 Braincells, Inc. Combinaisons contenant un dérivé de 4-acylaminopyridine
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TWI425945B (zh) * 2007-05-28 2014-02-11 Seldar Pharma Inc 四氫異喹啉－１－酮衍生物或其鹽
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5838157B2 (ja) * 2009-07-22 2015-12-24 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ Ｈｄａｃ阻害剤およびそれを用いる治療法
CN102153549B (zh) * 2010-12-14 2012-11-14 华东理工大学 γ咔啉化合物、制备方法和用途
CA2908542C (fr) 2013-04-29 2017-08-01 Chong Kun Dang Pharmaceutical Corp. Nouveaux composes pour inhibiteurs selectifs d'histone desacetylases et composition pharmaceutique les comprenant
WO2015051035A1 (fr) 2013-10-01 2015-04-09 The J. David Gladstone Institutes Compositions, systèmes et procédés pour le criblage de médicament de bruit d'expression génétique et leurs utilisations
CN108084178B (zh) * 2018-01-04 2020-09-01 济南大学 一类含有四氢-β-咔碄结构的异羟肟酸类化合物的用途
CN108558653A (zh) * 2018-05-14 2018-09-21 湖南华腾制药有限公司 赛乐西帕中间体及赛乐西帕的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
WO1990002119A1 (fr) * 1988-08-18 1990-03-08 Banyu Pharmaceutical Co., Ltd. Derives de 1,2,3,4-tetrahydro-isoquinoline
US5369108A (en) * 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
WO1998007421A1 (fr) * 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Composition medicinale
WO1998015525A1 (fr) * 1996-10-07 1998-04-16 Sumitomo Pharmaceuticals Co., Ltd. Acides hydroxamiques
AUPO721997A0 (en) 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
JP2003525203A (ja) * 1999-03-22 2003-08-26 ダーウィン・ディスカバリー・リミテッド ヒドロキサムおよびカルボン酸誘導体

Also Published As

Publication number Publication date
YU48803A (sh) 2006-05-25
KR100836545B1 (ko) 2008-06-10
PL365531A1 (en) 2005-01-10
EP1353921A1 (fr) 2003-10-22
EP1353921B1 (fr) 2006-04-19
MXPA03005713A (es) 2003-10-06
US6800638B2 (en) 2004-10-05
HUP0400554A2 (hu) 2004-06-28
CZ20031940A3 (cs) 2003-10-15
CN1483033A (zh) 2004-03-17
JP2004516325A (ja) 2004-06-03
SK9122003A3 (en) 2004-02-03
BG107935A (bg) 2004-08-31
US20040053960A1 (en) 2004-03-18
AR035513A1 (es) 2004-06-02
NO20032830D0 (no) 2003-06-20
CN1213046C (zh) 2005-08-03
ZA200304264B (en) 2004-08-30
DE60118975D1 (de) 2006-05-24
RU2003122190A (ru) 2005-02-27
CA2431471A1 (fr) 2002-07-04
RU2276140C2 (ru) 2006-05-10
AU2002226397B2 (en) 2006-10-05
WO2002051842A1 (fr) 2002-07-04
NZ526189A (en) 2004-10-29
IL156131A0 (en) 2003-12-23
BR0116402A (pt) 2003-11-11
ECSP034664A (es) 2003-07-25
NO20032830L (no) 2003-08-04
KR20030063424A (ko) 2003-07-28
ATE323700T1 (de) 2006-05-15
DE60118975T2 (de) 2006-12-21
ES2261519T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
IL156131A0 (en) Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
MA27001A1 (fr) Derives spirotricycliques nouveaux et leur utilisation comme inhibiteurs de phospho-diesterase-7
MA26771A1 (fr) Benzoheterocycles et leur utilisation comme inhibiteurs de mek.
AR028576A1 (es) Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa
DK1181269T3 (da) Celleproliferationsinhibitorer
MA25916A1 (fr) Nouveaux thiadiazoles et oxadiazoles et leur utilisation comme inhibiteurs de la phosphodiesterase-7
PT1220831E (pt) Novos derivados eter biarilico uteis como inibidores de recaptacao de monoamina
PL362917A1 (en) New mandelic acid derivatives and their use as throbin inhibitors
PT1185529E (pt) Pirazolobenzodiazepinas como inibidores de cdk2
DE60103935D1 (de) Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation
FR12C0019I1 (fr) O-cyclopropyle-carboxanilides et leur utilisation comme fongicides
ATE306480T1 (de) Trizyclische alkylhydroxamate, ihre herstellung und ihre verwendung als inhibitoren der zellproliferation
PT1287001E (pt) Derivados de tiofeno uteis como agentes anticancerigenos
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
FR2807052B1 (fr) Compositions silico-acryliques, leur procede de preparation et leur utilisation
PT1189907E (pt) Tienopirimidinas como inibidores da fosfodiesterase
PL349769A1 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
HUP0202401A2 (en) Five-membered heterocyclic amidinec as prodrugs of thrombin inhibitors, pharmaceutical compositions comprising thereof and their use
AR028068A1 (es) Nuevos derivados de 1,1-dioxotiocromano y su uso como inhibidores de trombina
PL352432A1 (en) Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them
DE60120930D1 (de) Neues ethylencopolymer und dessen verwendungen
MA28847B1 (fr) Derives de pyrrole, leur preparation et leur utilisation en therapeutique
PT1294677E (pt) Benzofanonas e sulfonas como inibidores de absorcao
DZ3367A1 (fr) Derives de 2-aminothiazoline et leur utilisation comme inhibiteurs de no-synthase
AU2001240025A1 (en) Cell cycle proteins associated with rad9, compositions and methods of use